Patients and healthcare workers experience with a mobile application for self-management of diabetes in Qatar: A Cross-sectional qualitative study (Preprint)
BACKGROUND Diabetes mellitus (DM) is highly prevalent in Qatar and the Middle East and North Africa (MENA) region. Mobile health (m-health) can improve communications between diabetic patients and medical teams and this, in turn, may enhance engagement and self-management. Droobi is a multi-language mobile application designed to support self-management of patients with DM. OBJECTIVE The study aimed to explore experiences of patients and educators about their communication before and after implementation of Droobi, a diabetes management app. METHODS We interviewed a convenience sample consisting of 9 patients and 5 nurse educators. Before interviews, Droobi was downloaded to participants’ mobile phone, and their profile on the application was created. To ensure optimum usage experience, all participants received education on how to use Droobi. Participants used Droobi for 6 to 12 weeks. All interviews were audio recorded, transcribed by professionals, and thematically analyzed. RESULTS Two main themes were generated from participants’ responses. The first theme relates to experiences of patients and educators about their communication before Droobi and consists of 3 sub-themes: (1) how patients communicated with medical team before Droobi (previous methods), (2) adoption of previous communication methods, and (3) shortcomings of previous communication methods. The second theme relates to experiences of patients and educators about their communication after Droobi and consists of 4 sub-themes: (1) adoption of Droobi, (2) advantages of Droobi, (3) shortcomings of Droobi, and (4) improvements suggested by educators and patients. Findings suggest that Droobi provided a more efficient and convenient way for communication between health workers and patients, yet multiple shortcomings and several suggestions for improvements were noted. CONCLUSIONS Droobi has the potential to overcome disadvantages of previous communication methods, thereby increasing diabetic patient self-management. However, continuing use of Droobi is a factor for continuing its long-term viability and eventual success. Future work should continue on evaluating the Droobi app and to include a number of different stakeholders (e.g., diabetic patients, educators, doctors, researchers) when developing the upcoming Droobi version taking into account the limitations and suggestions put forth by the end-users. Further studies are needed to assess the clinical and cost effectiveness of Droobi in Qatar and the MENA region together with investigating factors affecting its initial and continued use.